Claire Buchta Rosean

Claire Buchta Rosean has extensive experience in the field of scientific research and development. Claire started their career as a Graduate Student/Research Assistant at the University of Iowa in 2008, where they conducted research on cell-based immunotherapy and the regulation of Toll-like receptors in melanoma. Claire utilized various techniques such as ELISA, Western blotting, and multicolor flow cytometry.

In 2014, Claire transitioned to the role of Postdoctoral Research Associate in the Norian lab at the University of Iowa. Here, they focused on the correlation between obesity and the involvement of myeloid-derived suppressor cells (MDSCs) in the development of cancers like sarcoma and renal cell carcinoma. Claire analyzed serum cytokines and peripheral blood mononuclear cells from human cancer patients and utilized techniques such as multiplex and immunohistochemistry.

In 2015, Claire joined the University of Virginia as a Postdoctoral Research Fellow in the Rutkowski lab. Claire'sresearch centered around the effects of commensal dysbiosis on the tumor microenvironment in breast cancer development, progression, and response to immunotherapy. Claire employed techniques including multi-color flow cytometry, ELISA, and immunohistochemistry.

In 2019, Claire moved into the industry and became a Scientist I at Immunomic Therapeutics, Inc. Claire developed and tested nucleic acid vaccines against viral-derived targets, primarily in oncology. Claire also served as the non-clinical lead for the ITI-3000 and ITI-1001 project teams. Claire'sresponsibilities included designing and monitoring biodistribution and toxicity studies for ITI-3000, a nucleic acid vaccine indicated for use in Merkel cell carcinoma.

Claire's contributions in the field of scientific research and development have been significant, and they have amassed a diverse range of skills and expertise throughout their career.

Claire Buchta Rosean pursued their education in a systematic manner. Claire first attended St. Olaf College from 2004 to 2008, where they earned a Bachelor of Arts degree in Biology/Biological Sciences. Building upon this foundation, they then enrolled at the University of Iowa from 2008 to 2014. During this time, they completed their Doctor of Philosophy (PhD) in Immunology. These educational achievements reflect their dedication and commitment to understanding the complexities of biological systems and immunology.